Alliance Global Partners Maintains Buy on XORTX Therapeutics, Raises Price Target to $14
Xyratex Ltd -5.62% Pre
Xyratex Ltd XRTX | 2.35 2.35 | -5.62% 0.00% Pre |
Alliance Global Partners analyst James Molloy maintains XORTX Therapeutics (NASDAQ:
XRTX) with a Buy and raises the price target from $9 to $14.